1	Inovio	inovio	NNP	p2=IN	2	nn	_
2	Pharmaceuticals	pharmaceuticals	NNP	p2=NNPS	3	nsubj	3:A0=PAG
3	announced	announce	VBD	pb=announce.01	0	root	_
4	that	that	IN	_	7	complm	_
5	it	it	PRP	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	acquired	acquire	VBN	pb=acquire.01	3	ccomp	3:A1=PPT
8	global	global	JJ	_	9	amod	_
9	rights	right	NNS	_	7	dobj	7:A1=PPT
10	excluding	exclude	VBG	_	9	prep	_
11	China	china	NNP	_	10	pobj	_
12	for	for	IN	_	7	prep	7:A3=VSP
13	early	early	JJ	p2=RB	15	amod	_
14	preclinical	preclinical	JJ	_	15	amod	_
15	therapies	therapy	NNS	_	12	pobj	_
16	for	for	IN	_	15	prep	_
17	Alzheimer	alzheimer	NNP	_	19	poss	_
18	's	's	POS	_	17	possessive	_
19	disease	disease	NN	_	16	pobj	_
20	and	and	CC	_	19	cc	_
21	multiple	multiple	JJ	_	22	amod	_
22	sclerosis	sclerosis	NN	_	19	conj	_
23	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	therapies	therapy	NNS	_	4	nsubjpass	4:A1=PPT
3	are	be	VBP	_	4	auxpass	_
4	based	base	VBN	pb=base.02	0	root	_
5	on	on	IN	_	4	prep	4:A2=DIR
6	the	the	DT	_	7	det	_
7	work	work	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	Dr.	dr.	NNP	_	11	nn	_
10	Bin	bin	NNP	_	11	nn	_
11	Wang	wang	NNP	_	8	pobj	_
12	,	,	,	_	11	punct	_
13	a	a	DT	_	14	det	_
14	professor	professor	NN	_	11	appos	_
15	at	at	IN	_	14	prep	_
16	Fudan	fudan	NNP	_	17	nn	_
17	University	university	NNP	_	21	poss	_
18	's	's	POS	_	17	possessive	_
19	Shanghai	shanghai	NNP	_	21	nn	_
20	Medical	medical	NNP	_	21	nn	_
21	College	college	NNP	_	15	pobj	_
22	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	it	it	PRP	_	6	nsubj	6:A0=PAG
5	will	will	MD	_	6	aux	6:AM-MOD
6	make	make	VB	pb=make.02	3	ccomp	3:A1=PPT
7	clinical	clinical	JJ	_	11	amod	_
8	and	and	CC	_	7	cc	_
9	regulatory	regulatory	JJ	_	7	conj	_
10	milestone	milestone	NN	_	11	nn	_
11	payments	payment	NNS	_	6	dobj	6:AM-PRR
12	to	to	IN	_	11	prep	_
13	the	the	DT	_	14	det	_
14	University	university	NNP	_	12	pobj	_
15	in	in	IN	_	14	prep	_
16	view	view	NN	_	15	pobj	_
17	of	of	IN	_	16	prep	_
18	Dr.	dr.	NNP	_	19	nn	_
19	Wang	wang	NNP	_	22	poss	_
20	's	's	POS	_	19	possessive	_
21	academic	academic	JJ	_	22	amod	_
22	research	research	NN	_	17	pobj	_
23	.	.	.	_	3	punct	_

1	Dr.	dr.	NNP	_	2	nn	_
2	Wang	wang	NNP	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	authored	author	VBN	pb=author.01	0	root	_
5	several	several	JJ	_	4	dobj	4:A1=PPT
6	of	of	IN	_	5	prep	_
7	the	the	DT	_	11	det	_
8	earliest	early	JJS	_	11	amod	_
9	DNA	dna	NN	p2=NNP	10	nn	_
10	vaccine	vaccine	NN	_	11	nn	_
11	papers	paper	NNS	_	6	pobj	_
12	and	and	CC	_	11	cc	_
13	patents	patent	NNS	_	11	conj	_
14	.	.	.	_	4	punct	_

1	He	he	PRP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	worked	work	VBN	pb=work.01	0	root	_
4	closely	closely	RB	_	3	advmod	3:AM-MNR
5	with	with	IN	_	3	prep	3:A3=COM
6	Dr.	dr.	NNP	_	8	nn	_
7	David	david	NNP	_	8	nn	_
8	Weiner	weiner	NNP	_	5	pobj	_
9	at	at	IN	_	8	prep	_
10	the	the	DT	_	11	det	_
11	University	university	NNP	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	Pennsylvania	pennsylvania	NNP	_	12	pobj	_
14	.	.	.	_	3	punct	_

1	Dr.	dr.	NNP	_	2	nn	_
2	Wang	wang	NNP	_	6	nsubj	6:A0
3	and	and	CC	_	2	cc	_
4	Dr.	dr.	NNP	_	5	nn	_
5	Weiner	weiner	NNP	_	2	conj	_
6	discovered	discover	VBD	pb=discover.01	0	root	_
7	a	a	DT	_	9	det	_
8	new	new	JJ	_	9	amod	_
9	method	method	NN	_	6	dobj	6:A1=PPT
10	of	of	IN	_	9	prep	_
11	generating	generate	VBG	p2=NN|pb=generate.01	10	pcomp	_
12	inducible	inducible	JJ	_	15	amod	_
13	regulatory	regulatory	JJ	_	15	amod	_
14	T	t	NN	_	15	nn	_
15	cells	cell	NNS	_	11	dobj	11:A1=PPT
16	(	(	-LRB-	_	17	punct	_
17	iTreg	itreg	NNP	p2=RB	15	appos	_
18	)	)	-RRB-	_	17	punct	_
19	.	.	.	_	6	punct	_

1	The	the	DT	_	2	det	_
2	researchers	researcher	NNS	_	3	nsubj	6:A0=PAG;3:A1=PPT
3	were	be	VBD	pb=be.01	0	root	_
4	able	able	JJ	_	3	acomp	3:A2=PRD
5	to	to	TO	_	6	aux	_
6	generate	generate	VB	pb=generate.01	4	xcomp	_
7	CD25	cd25	NNP	p2=CD	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	iTreg	itreg	NNP	_	10	nn	_
10	cells	cell	NNS	p2=VBZ	6	dobj	6:A1=PPT
11	in	in	IN	_	6	prep	6:AM-MNR
12	an	an	DT	_	16	det	_
13	antigen	antigen	JJ	p2=NN	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	specific	specific	JJ	p2=NN	16	amod	_
16	manner	manner	NN	_	11	pobj	21:A1=PPT;23:A1
17	,	,	,	_	16	punct	_
18	which	which	WDT	_	21	nsubjpass	21:R-A1;23:R-A2
19	could	could	MD	_	21	aux	21:AM-MOD
20	be	be	VB	_	21	auxpass	_
21	used	use	VBN	pb=use.01	16	rcmod	_
22	to	to	TO	_	23	aux	_
23	develop	develop	VB	pb=develop.02	21	xcomp	21:A2=PRP
24	therapies	therapy	NNS	_	23	dobj	25:A0=PAG;23:A1=PRD
25	targeting	target	VBG	pb=target.01	24	partmod	_
26	inflammatory	inflammatory	JJ	_	27	amod	_
27	diseases	disease	NNS	_	25	dobj	25:A1=PPT
28	,	,	,	_	27	punct	_
29	including	include	VBG	_	27	prep	_
30	multiple	multiple	JJ	_	31	amod	_
31	sclerosis	sclerosis	NN	p2=NNS	29	pobj	_
32	and	and	CC	_	31	cc	_
33	Alzheimer	alzheimer	NNP	_	35	poss	_
34	's	's	POS	_	33	possessive	_
35	disease	disease	NN	_	31	conj	_
36	.	.	.	_	3	punct	_

1	MS	ms	NNP	p2=PRP	2	nsubj	2:A0=PAG
2	affects	affect	VBZ	pb=affect.01	0	root	_
3	more	more	JJR	_	5	amod	_
4	than	than	IN	_	5	quantmod	_
5	350,000	0	CD	_	6	num	_
6	patients	patient	NNS	_	2	dobj	2:A1=PPT
7	in	in	IN	_	6	prep	_
8	the	the	DT	_	9	det	_
9	U.S.	u.s.	NNP	_	7	pobj	_
10	alone	alone	RB	_	9	advmod	_
11	and	and	CC	_	6	cc	_
12	about	about	RB	p2=IN	14	quantmod	_
13	2.5	0	CD	_	14	number	_
14	million	#crd#	CD	_	6	conj	_
15	worldwide	worldwide	RB	_	14	advmod	_
16	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	disease	disease	NN	_	3	nsubj	3:A1=PPT;14:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	a	a	DT	_	7	det	_
5	chronic	chronic	JJ	_	7	amod	_
6	inflammatory	inflammatory	JJ	_	7	amod	_
7	disease	disease	NN	_	3	attr	3:A2=PRD
8	of	of	IN	_	7	prep	_
9	the	the	DT	_	12	det	_
10	central	central	JJ	_	12	amod	_
11	nervous	nervous	JJ	_	12	amod	_
12	system	system	NN	_	8	pobj	_
13	and	and	CC	_	3	cc	_
14	is	be	VBZ	pb=be.01	3	conj	_
15	one	#crd#	CD	_	14	attr	14:A2=PRD
16	of	of	IN	_	15	prep	_
17	the	the	DT	_	19	det	_
18	leading	leading	JJ	p2=VBG	19	amod	_
19	causes	cause	NNS	_	16	pobj	_
20	of	of	IN	_	19	prep	_
21	non-traumatic	non-traumatic	JJ	_	22	amod	_
22	disability	disability	NN	_	20	pobj	_
23	among	among	IN	_	19	prep	_
24	young	young	JJ	_	25	amod	_
25	adults	adult	NNS	_	23	pobj	_
26	and	and	CC	_	25	cc	_
27	middle	middle	NN	p2=JJ	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	aged	aged	JJ	_	30	amod	_
30	people	people	NNS	_	25	conj	_
31	.	.	.	_	3	punct	_

1	AD	ad	NN	_	2	nsubj	13:A0=PAG;2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	the	the	DT	_	6	det	_
4	sixth	#ord#	JJ	_	6	amod	_
5	leading	lead	VBG	p2=NN|pb=lead.01	6	amod	_
6	cause	cause	NN	p2=IN	2	attr	5:A0=PAG;2:A2=PRD
7	of	of	IN	_	6	prep	_
8	death	death	NN	_	7	pobj	_
9	in	in	IN	_	6	prep	_
10	the	the	DT	_	11	det	_
11	U.S.	u.s.	NNP	_	9	pobj	_
12	and	and	CC	_	2	cc	_
13	affects	affect	VBZ	pb=affect.01	2	conj	_
14	approximately	approximately	RB	_	16	advmod	_
15	5.2	0	CD	_	16	number	_
16	million	#crd#	CD	_	18	num	_
17	U.S.	u.s.	NNP	_	18	nn	_
18	patients	patient	NNS	_	13	dobj	13:A1=PPT
19	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	annual	annual	JJ	_	3	amod	_
3	figure	figure	NN	_	10	nsubjpass	10:A1=PPT;12:A1=PPT
4	of	of	IN	_	3	prep	_
5	new	new	JJ	_	6	amod	_
6	cases	case	NNS	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	AD	ad	NN	_	7	pobj	_
9	is	be	VBZ	_	10	auxpass	_
10	forecasted	forecast	VBN	pb=forecast.01	0	root	_
11	to	to	TO	p2=IN	12	aux	_
12	double	double	VB	pb=double.01	10	xcomp	10:C-A1
13	by	by	IN	_	12	prep	12:AM-TMP
14	2050	0	CD	_	13	pobj	_
15	.	.	.	_	10	punct	_

1	The	the	DT	_	2	det	_
2	technologies	technology	NNS	_	4	nsubjpass	4:A1=PPT
3	are	be	VBP	_	4	auxpass	_
4	based	base	VBN	pb=base.02	0	root	_
5	on	on	IN	_	4	prep	4:A2=DIR
6	patent	patent	NN	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	protected	protect	VBN	_	5	amod	_
9	and	and	CC	_	8	cc	_
10	published	publish	VBN	pb=publish.01	8	conj	_
11	work	work	NN	_	10	dobj	10:A1=PRD
12	of	of	IN	_	11	prep	_
13	the	the	DT	_	14	det	_
14	researchers	researcher	NNS	_	12	pobj	19:A1=PPT
15	,	,	,	_	14	punct	_
16	which	which	WDT	_	19	dobj	19:R-A1
17	Inovio	inovio	NNP	p2=VBP	19	nsubj	19:A0=PAG
18	has	have	VBZ	_	19	aux	_
19	licensed	license	VBN	pb=license.01	14	rcmod	_
20	as	as	IN	_	19	prep	19:A2=GOL
21	preclinical	preclinical	JJ	_	23	amod	_
22	synthetic	synthetic	JJ	_	23	amod	_
23	products	product	NNS	_	20	pobj	_
24	as	as	IN	_	23	prep	_
25	treatment	treatment	NN	_	24	pobj	_
26	for	for	IN	_	25	prep	_
27	the	the	DT	_	31	det	_
28	two	#crd#	CD	_	31	num	_
29	major	major	JJ	_	31	amod	_
30	inflammatory	inflammatory	JJ	_	31	amod	_
31	diseases	disease	NNS	_	26	pobj	_
32	.	.	.	_	4	punct	_

